NCT06421168Completed
Lung Function in Bariatric Surgery Candidates
The Impact of Body Mass Index on Lung Function in Bariatric Surgery Candidates
Source: ClinicalTrials.gov · Last updated 20 May 2024
Brief summary (registry, in English)
This study aims to retrospectively investigate the impact of body mass index on lung function metrics, e.g. FEV1%, FVC%, FEV1/FVC%.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1834 (actual)
- First submitted
- 13 May 2024
- Start date
- 1 Sept 2017
- Primary completion date
- 31 Aug 2023
- Lead sponsor
- China-Japan Friendship Hospital
- Diseases
- Obesity
- NCT number
- NCT06421168
What you commit to
- Study type: Observational
- Participants enrolled: 1834
- From 1 Sept 2017 to the primary completion date, 31 Aug 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with a history of lung surgery and/or respiratory diseases (e.g. asthma, pulmonary emphysema, and interstitial pulmonary fibrosis).
Who the study is looking for
- Subjects with obesity (BMI ≥ 27.5 kg/m2 according to Chinese guidelines, guidelines from the American Society for Metabolic and Bariatric Surgery and International Federation for the Surgery of Obesity and Metabolic Disorders);
- Age \> 16 years;
- Complete preoperative pulmonary function tests
Age in the registry: 16 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Yuntao Nie Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.